more details about the commercial arrangements going down the track would be good, but perhaps they are not worked out as yet- $1 m seem lousy to get it started really, and is merely a cratch of a few skin cells to AstraZeneca
- it is to be assumed the executives here are just not giving the technology away for peanuts ( though most likely are!)
Ann: AstraZeneca Partners LBT for APAS Pharma Development, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
